• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40G; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 1X40G; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problems Insufficient Information (3190); Appropriate Term/Code Not Available (3191)
Patient Problems Bradycardia (1751); Foreign Body Reaction (1868)
Event Date 01/11/2018
Event Type  Injury  
Manufacturer Narrative
(b)(4).Udi unique device identifier (b)(4).Report source- foreign.The event occurred in (b)(6).The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event Description
It was reported that a moment after implantation of cement blood pressure suddenly dropped and bradycardia was observed.Later during surgery but after the implantation there was also blood loss.Position during operation - on back, method of implantation - cemented.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.The device was not returned to the manufacturer.Therefore it could not be analyzed.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.No non-conformity has been detected which could be linked to the issue and the root cause could not be determined.This complaint is closed but could be reopened if the product is received later.Please note that bone cement implantation syndrome is a known risk with cement.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
Please refer to report 3006946279-2018-00030.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 1X40G
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key7258604
MDR Text Key99587883
Report Number3006946279-2018-00030
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
PK150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2020
Device Model NumberN/A
Device Catalogue Number4003940001
Device Lot NumberA733BA3102
Other Device ID NumberSEE H10 NARRATIVE
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age78 YR
Patient Weight92
-
-